ATE352298T1 - Verfahren zur behandlung von dermatosen mit einer avermectin-verbindung - Google Patents

Verfahren zur behandlung von dermatosen mit einer avermectin-verbindung

Info

Publication number
ATE352298T1
ATE352298T1 AT02766531T AT02766531T ATE352298T1 AT E352298 T1 ATE352298 T1 AT E352298T1 AT 02766531 T AT02766531 T AT 02766531T AT 02766531 T AT02766531 T AT 02766531T AT E352298 T1 ATE352298 T1 AT E352298T1
Authority
AT
Austria
Prior art keywords
avermectin compound
treating dermatoses
kit
acne
dermatitis
Prior art date
Application number
AT02766531T
Other languages
English (en)
Inventor
L Dean Parks
Original Assignee
L Dean Parks
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by L Dean Parks filed Critical L Dean Parks
Application granted granted Critical
Publication of ATE352298T1 publication Critical patent/ATE352298T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
AT02766531T 2001-10-12 2002-10-03 Verfahren zur behandlung von dermatosen mit einer avermectin-verbindung ATE352298T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/976,915 US6399651B1 (en) 2000-06-29 2001-10-12 Method of treating dermatoses using avermectin compound

Publications (1)

Publication Number Publication Date
ATE352298T1 true ATE352298T1 (de) 2007-02-15

Family

ID=25524622

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02766531T ATE352298T1 (de) 2001-10-12 2002-10-03 Verfahren zur behandlung von dermatosen mit einer avermectin-verbindung

Country Status (9)

Country Link
US (2) US6399651B1 (de)
EP (1) EP1450785B1 (de)
AT (1) ATE352298T1 (de)
CY (1) CY1106528T1 (de)
DE (1) DE60217900T2 (de)
DK (1) DK1450785T3 (de)
ES (1) ES2278046T3 (de)
PT (2) PT1450785E (de)
WO (1) WO2003032976A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7897559B2 (en) * 2000-06-29 2011-03-01 Parks L Dean Dermatological composition and kit containing avermectin compound for treating dermatological conditions
US6399651B1 (en) * 2000-06-29 2002-06-04 L. Dean Parks Method of treating dermatoses using avermectin compound
FR2854074B1 (fr) * 2003-04-24 2007-11-23 Galderma Res & Dev Utilisation de l'ivermectine pour le traitement de desordres dermatologiques
RU2350333C3 (ru) * 2003-04-24 2018-08-24 Галдерма С.А. Применение ивермектина для лечения дерматологических расстройств
GB0316377D0 (en) * 2003-07-12 2003-08-13 Norbrook Lab Ltd Parasiticidal composition
US7714015B2 (en) * 2003-08-07 2010-05-11 Lil Brat Pharmaceuticals Of Marlette, Mi Method and composition for treating sunburned skin
DE102004009904A1 (de) * 2004-02-26 2005-09-22 Grünenthal GmbH Kit aus einem gegebenenfalls wirkstoffhaltigen Pflaster und einem Hautirritationen verhindernden Mittel
FR2867684B1 (fr) * 2004-03-18 2006-05-05 Galderma Sa Gel creme contenant de l'ivermectine
DE602005020912D1 (de) * 2004-03-18 2010-06-10 Galderma Sa Ivermectin enthaltende creme
FR2894823B1 (fr) * 2005-12-20 2008-02-29 Galderma Sa Composition de type emulsion inverse comprenant de l'ivermectine, et ses utilisations en cosmetique et en dermatologie
FR2900052B1 (fr) * 2006-04-19 2011-02-18 Galderma Sa Composition comprenant au moins une phase aqueuse et au moins une phase grasse comprenant de l'ivermectine
FR2906468B1 (fr) * 2006-09-28 2012-09-21 Galderma Sa Utilisation de composes de la famille des avermectines pour le traitement de desordres dermatologiques
US8791153B2 (en) 2006-10-12 2014-07-29 Sanofi-Topaz, Inc. Topical avermectin formulations and methods for elimination and prophylaxis of susceptible and treatment-resistant strains of head lice
US8901163B2 (en) 2007-01-03 2014-12-02 Galderma S.A. Method of treating hyperesthesia, paresthesia, dolor, and pruritus caused by insect stings or noxious weeds or plants using avermectin compound
US20080226701A1 (en) * 2007-03-15 2008-09-18 John Deignan Medicated patches
US8541022B2 (en) * 2008-06-02 2013-09-24 Galderma S.A. Method of treating burns using avermectin compound
FR2937972B1 (fr) 2008-11-04 2013-03-29 Galderma Res & Dev Derives d'oxoazetidine, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique
CA2811924C (en) 2010-10-20 2015-06-16 Galderma S.A. Method of treating hemorrhoids using macrocyclic lactone compound
CA2811926A1 (en) 2010-10-20 2012-04-26 Galderma S.A. Method of treating otitis externa using macrocyclic lactone compound
US8722636B2 (en) * 2011-01-31 2014-05-13 New Market Pharmaceuticals, LLC Animal treatments
CN102599178B (zh) * 2012-02-13 2013-11-27 中国水稻研究所 异丙威和依维菌素复配农药
AU2012379005B2 (en) 2012-05-02 2017-12-21 Newmarket Pharmaceuticals Llc Pharmaceutical compositions for direct systemic introduction
US9782425B2 (en) 2013-07-08 2017-10-10 Galderma S.A. Treatment of papulopustular rosacea with ivermectin
US9233117B2 (en) 2013-07-08 2016-01-12 Galderma S. A. Treatment of inflammatory lesions of rosacea with ivermectin
EP3074021B1 (de) * 2013-11-29 2021-05-12 Galderma SA Verbindung der avermectin-familie oder der milbemycin-familie zur behandlung und/oder prävention von atopischer dermatitis

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE434277B (sv) * 1976-04-19 1984-07-16 Merck & Co Inc Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis
US5439924A (en) * 1991-12-23 1995-08-08 Virbac, Inc. Systemic control of parasites
US5786344A (en) * 1994-07-05 1998-07-28 Arch Development Corporation Camptothecin drug combinations and methods with reduced side effects
US5654312A (en) * 1995-06-07 1997-08-05 Andrulis Pharmaceuticals Treatment of inflammatory and/or autoimmune dermatoses with thalidomide alone or in combination with other agents
US5773422A (en) * 1996-01-29 1998-06-30 Komer; Gene Avermectin formulation
US6057372A (en) * 1996-06-11 2000-05-02 Soda Aromatic Co., Ltd. Antibacterial agents and cosmetics and clothing containing the same
US5952372A (en) * 1998-09-17 1999-09-14 Mcdaniel; William Robert Method for treating rosacea using oral or topical ivermectin
US6262031B1 (en) * 1999-03-12 2001-07-17 Merck & Co., Inc. Method for treating pediculosis capitisinfestation
US6133310A (en) * 1999-08-26 2000-10-17 Parks; L. Dean Method of treatment of rosacea
US6399651B1 (en) * 2000-06-29 2002-06-04 L. Dean Parks Method of treating dermatoses using avermectin compound
US6319945B1 (en) * 2000-06-29 2001-11-20 L. Dean Parks Method of treatment of seborrheic dermatitis
US6399652B1 (en) * 2000-06-29 2002-06-04 L. Dean Parks Method of treating acne vulgaris using avermectin compound

Also Published As

Publication number Publication date
US20020156029A1 (en) 2002-10-24
PT1439832E (pt) 2007-06-05
EP1450785A1 (de) 2004-09-01
US6399651B1 (en) 2002-06-04
ES2278046T3 (es) 2007-08-01
DE60217900T2 (de) 2007-11-08
EP1450785B1 (de) 2007-01-24
EP1450785A4 (de) 2005-01-05
US20020035076A1 (en) 2002-03-21
WO2003032976A1 (en) 2003-04-24
DK1450785T3 (da) 2007-05-14
DE60217900D1 (de) 2007-03-15
PT1450785E (pt) 2007-04-30
CY1106528T1 (el) 2012-01-25

Similar Documents

Publication Publication Date Title
ATE352298T1 (de) Verfahren zur behandlung von dermatosen mit einer avermectin-verbindung
BR0312078A (pt) controle de informações de localização geográfica de dispositivos que operam em sistemas de comunicação sem fio
CY1121135T1 (el) Ενωσεις υποκατεστημενης τετρακυκλιnhς για την θεραπευτικη αγωγη φλεγμονωδων διαταραχων του δερματος
BRPI0506977A (pt) composto de tetrahidrocarbolina como agentes anticáncer
ES2159309T3 (es) Semillas tratadas.
PT1543011E (pt) Composto de tienopirrolilo e furanopirrolilo e sua utilizacao como ligandos do receptor h4 da histamina
PT1318992E (pt) Derivados do imidazole como inibidores da cinase raf
EA200000282A1 (ru) Способ введения таксана пациенту, нуждающемуся в лечении таксаном, способ лечения человека таксаном (варианты)
ATE430589T1 (de) Wasserbehandlung zur kontrolle von biobewuchs mittels stabilisierter bromlösungen
BRPI0518776A2 (pt) composiÇço e mÉtodo para o cuidado oral, e, mÉtodos para inibir a inflamaÇço em um tecido oral de um paciente, e para promover a saéde oral em um paciente
DK1596880T3 (da) Fremgangsmåder og sammensætninger til undertrykkelse af fibrocytdifferentiering
WO2005000213A3 (en) Method for treating diseases using HSP90-inhibiting agents in combination with enzyme inhibitors
WO2004050033A3 (en) Method of treating cancers
WO2005105094A3 (en) Cancer treatment method
NO20053649D0 (no) Kombinasjonsterapi
DE60220290D1 (de) Pyridinderivate als inhibitoren der raf-kinase
DK1427409T3 (da) Fremgangsmåde til behandling eller forhindring af vaskulær inflammation under brug af en eller flere sterolabssorptionsinhibitorer
DE602004022285D1 (de) Verfahren zur behandlung von erkrankungen mit hsp90-hemmenden mitteln in kombination mit antimitotika
MX9308013A (es) 4-fenil-piridonas y 4-fenil-2-fenil-2-alcoxipiridinas sustituidas, procedimiento para su preparacion y medicamentos que los contienen.
BR0215362A (pt) método para melhorar a aparência estética da pele
WO2015017328A3 (en) Organophosphates for treating afflictions of the skin
WO2003103473A3 (en) APPARATUS AND METHOD FOR SURGICAL INTERVENTION
ATE383863T1 (de) Kombinationschemotherapie
WO2004043424A8 (en) Method of stimulating hair growth using benzopyrans
AR040287A1 (es) Plataforma para formulaciones transdermicas (pft)

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1450785

Country of ref document: EP